Zimmer Biomet Holdings Inc. (NYSE: ZBH) is -1.22% lower on its value in year-to-date trading and has touched a low of $100.39 and a high of $135.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZBH stock was last observed hovering at around $124.09 in the last trading session, with the day’s gains setting it 1.85% off its average median price target of $127.50 for the next 12 months. It is also 13.14% off the consensus price target high of $145.00 offered by 27 analysts, but current levels are -25.94% lower than the price target low of $100.00 for the same period.
Currently trading at $125.94, the stock is 0.34% and 3.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.3 million and changing 1.49% at the moment leaves the stock 9.24% off its SMA200. ZBH registered 5.51% gain for a year compared to 6-month gain of 17.70%.
The stock witnessed a 0.41% loss in the last 1 month and extending the period to 3 months gives it a 18.44%, and is 2.07% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.64% over the week and 1.87% over the month.
Zimmer Biomet Holdings Inc. (ZBH) has around 19500 employees, a market worth around $25.97B and $7.15B in sales. Current P/E ratio is 78.37 and Fwd P/E is 18.09. Profit margin for the company is 3.90%. Distance from 52-week low is 25.45% and -6.75% from its 52-week high. The company has generated returns on investments over the last 12 months (3.20%).
Zimmer Biomet Holdings Inc. (ZBH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Zimmer Biomet Holdings Inc. (ZBH) is a “Hold”. 27 analysts offering their recommendations for the stock have an average rating of 2.90, where 16 rate it as a Hold and 2 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.
Zimmer Biomet Holdings Inc. is expected to release its quarterly report on 05/02/2023.The EPS is expected to grow by 395.20% this year.
Zimmer Biomet Holdings Inc. (ZBH) Top Institutional Holders
The shares outstanding are 209.80M, and float is at 209.70M with Short Float at 1.44%.
Zimmer Biomet Holdings Inc. (ZBH) Insider Activity
A total of 9 insider transactions have happened at Zimmer Biomet Holdings Inc. (ZBH) in the last six months, with sales accounting for 5 and purchases happening 4 times. The most recent transaction is an insider sale by Phipps Chad F,the company’sSr. VP/Gen Counsel/Secretary. SEC filings show that Phipps Chad F sold 11,522 shares of the company’s common stock on Dec 13 at a price of $128.63 per share for a total of $1.48 million. Following the sale, the insider now owns 41880.0 shares.
Zimmer Biomet Holdings Inc. disclosed in a document filed with the SEC on Jul 05 that VAN ZUILEN WILFRED (Pres, Europe, M. East & Africa) sold a total of 531 shares of the company’s common stock. The trade occurred on Jul 05 and was made at $105.22 per share for $55870.0. Following the transaction, the insider now directly holds 2240.0 shares of the ZBH stock.
Still, SEC filings show that on Mar 17, Phipps Chad F (Sr. VP/Gen Counsel/Secretary) disposed off 35,149 shares at an average price of $121.97 for $4.29 million. The insider now directly holds 41,539 shares of Zimmer Biomet Holdings Inc. (ZBH).
Zimmer Biomet Holdings Inc. (ZBH): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.85% up over the past 12 months and Medtronic plc (MDT) that is -22.37% lower over the same period. Stryker Corporation (SYK) is 0.18% up on the 1-year trading charts.